Clinical Research

Redo TAVR: A 26-mm Sapien 3 device (Edwards Lifesciences) implanted within a 29-mm CoreValve device (Medtronic). Image courtesy of EuroIntervention.

Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves

Researchers took a closer look at the effectiveness of redo TAVR, implanting Sapien 3 valves into a variety of explanted CoreValve and Evolut valves.

Banner ASC in Sun City, Arizona.

Experts develop highly sensitive X-ray detector to minimize radiation dose, cut costs

The hope is that by creating detectors that are more sensitive, less ionizing radiation will be needed to produce diagnostic quality imaging.

AI system detects pneumothorax on chest x-rays

New study highlights the need to include more challenging datasets in AI training

A recent analysis of an already CE-marked, AI-based system that identifies pneumothorax on chest radiographs revealed a weak point in what has largely been considered a reliable support tool. 

Gilbert Tang, MD, explains new tricuspid TEER TRILUMINATE data that now shows clinical efficacy.

Tricuspid TEER shows clinical efficacy for first time in newest TRILUMINATE data

Gilbert Tang, MD, spoke to Cardiovascular Business about late-breaking data from the TRILUMINATE IDE trial. While early results were promising, these latest findings highlight the TriClip device's true value for the first time.

Field Museum using CT scans to study mummified subjects.

Mobile CT unit helps Field Museum experts gain new insight into ancient history

Using computed tomography allows researchers to study these individuals in a more sensitive, person-centered approach.

Ultrasound device developed to treat neuropathy

Ultrasound device could be 'promising breakthrough' for treating diabetic neuropathy

Up to one-third of people with diabetes will develop a foot ulcer in their lifetime, and up to 20% will require some form of amputation as a result.  

heart surgery surgeons

Concomitant ablation surgery during heart operations boosts long-term survival

Treating AFib with surgical ablation during mitral valve surgery and other common heart operations can help patients live longer, a new meta-analysis confirmed.

Sanjit Jolly, MD, says cholchicine failed to help heart attack patients in the CLEAR SYNERGY (OASIS 9) presented as a TCT 2024 late-breaker.

Cardiologist explores why colchicine failed to help heart attack patients

Sanjit S. Jolly, MD, MSc, reviewed his team's late-breaking data on treating heart attack patients with colchicine. "I think inflammation is an important area, but I don't think colchicine is the magic bullet," he said.